Labiotech 7 mai 2026 The rise of trispecific antibodies: Biopharma’s next big bet after bispecifics
Charles River 7 mai 2026 Charles River Laboratories (NYSE:CRL) Exceeds Q1 CY2026 Expectations - StockStory
Harvard Bioscience 7 mai 2026 When Should You Buy Harvard Bioscience, Inc. (NASDAQ:HBIO)? - simplywall.st
Samsung Biologics 7 mai 2026 Montgomery County’s economic growth continues in Q2 2026 - business.maryland.gov
Moderna 7 mai 2026 Moderna’s mRNA flu vaccine more effective than current SOC - Clinical Trials Arena
Endpoints News 7 mai 2026 Angelini fortifies neurology portfolio with $4.1B buyout of Catalyst Pharma
Eli Lilly 7 mai 2026 Pharma Pulse: GLP-1 Momentum Builds While Lilly Expands Genetic Medicine Manufacturing - Pharmaceutical Commerce
Siemens Healthineers 7 mai 2026 Weak Diagnostics segment weighs heavily on Siemens Healthineers - marketscreener.com
Siemens Healthineers 7 mai 2026 Earnings call transcript: Siemens Healthineers Q2 2026 sees stock plunge amid Diagnostics woes - Investing.com
Siemens Healthineers 7 mai 2026 Earnings call transcript: Siemens Healthineers Q2 2026 sees stock plunge amid Diagnostics woes - Investing.com
Insilico Medicine 7 mai 2026 Advancing Drug Discovery from Automation to Autonomy: Insilico Medicine Announces LabClaw the Intelligent System - Insilico Medicine
Moderna 7 mai 2026 Korea University and Moderna have been working on mRNA hantavirus vaccine since 2023 - Brussels Signal